1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes MellitusFemale Urogenital Diseases and Pregnancy Complications, Insulin Resistance, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, hyperinsulinism, metabolic disease, pregnancy disorderNot yet recruitingPhase 2 / Phase 32026-09-28NCT07797036